Related Experiment Video

Updated: Feb 24, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

3.0K

HIV-1 reservoirs in elite controllers: clues for developing a functional cure?

Megan E May1, Abena K Kwaa1, Joel N Blankson1

  • 1Center for AIDS Research, Department of Medicine, Johns Hopkins University School of Medicine, 855 N Wolfe Street, Rangos 552, Baltimore, MD 21205, USA.

Future Microbiology
|August 25, 2017
PubMed
Summary

No abstract available in PubMed .

Keywords:
CD8+ T cellsHIV/AIDSantiviral drugscARTelite controllersimmunitylatent reservoirsviral replication

More Related Videos

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

12.8K
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

16.2K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.9K